Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chinese medicine for treating thromboangitis obliterans

A technology for thrombotic occlusion and vasculitis, which is applied in the field of traditional Chinese medicine for the treatment of vasculitis, and can solve the problems of treating the symptoms but not the root cause, and poor treatment effect.

Inactive Publication Date: 2007-07-25
于曼秋
View PDF0 Cites 20 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Modern Chinese medicine generally uses "Xueshuantong" to treat vasculitis, but the treatment effect is not good; while Western medicine can only adopt the method of amputation, cutting off the necrotic part, and treating the symptoms cannot cure the root cause

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0010] Preferable: 5 parts of honeysuckle, 5 parts of Caulis Spatholobus, 5 parts of red peony, 5 parts of angelica, 5 parts of dandelion, 2 parts of safflower, 2 parts of peach kernel, 2 parts of trigonum, 2 parts of curcuma, 2 parts of papaya, 2 parts of ground beetle 5 parts of Dendrobium, 2 parts of Achyranthes, 3 parts of Astragalus, 5 parts of Pollen, 5 parts of Yuanshen, 1 part of Pangolin, 1.5 parts of Yuanhu, 1.5 parts of Frankincense, 1.5 parts of Myrrh, 2 parts of Fangji, Toosendan 5 parts, 5 parts of mulberry branch, 3 parts of cassia twig, 2 parts of Chuanxiong, 2 parts of Dilong, 2 parts of Atractylodes macrocephala, 3 parts of dried lacquer, 1 part of leech, 1 part of dried ginger and 2 parts of licorice, ground into powder without adding honey 10 servings made into pills.

[0011] Apply the clinical trial report of Chinese medicine of the present invention:

[0012] 1. General information: 100 patients with thromboangiitis obliterans, 80 males, aged 20-40 year...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A Chinese medicine for treating thromboangiitis obliterans, arteriosclerotic obliteration, aorto-arteritis and Raynaud's syndrome is prepared from 31 Chinese-medicinal materials including honeysuckle flower, red peony root, safflower, peach kernel, etc.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a traditional Chinese medicine for treating vasculitis. Background technique [0002] Thromboangiitis obliterans is one of the three major vascular diseases in my country, and its predisposing factors are closely related to smoking, sudden cold, and trauma. It is another intractable disease after cardiovascular and cerebrovascular diseases. The condition is stubborn and lingering. Once the disease occurs, it often puts the patient in great pain, and even becomes disabled due to untimely treatment. "Thromboangiitis obliterans" is called gangrene in traditional Chinese medicine. The invaded arteries are segmented like strings of beads, which form a thrombus blockage over time, causing blood circulation disorders in limbs, hypoxia in local tissues, and even ulceration. ,gangrene. Modern Chinese medicine generally uses "Xueshuantong" to treat vasculitis, but the curative effect is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9068A61P7/02A61P9/14A61K35/64A61K35/62A61K35/56A61K35/36
Inventor 于曼秋于曼宁于官正
Owner 于曼秋
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com